Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Non-randomized Study to Monitor for Adverse Drug Reactions Among Patients Administered Fedoruk-manufactured [F-18]-FDG Injection

NCT02811185 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT02811185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02811185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Non-randomized Study to Monitor for Adverse Drug Reactions Among Patients Administered Fedoruk-manufactured [F-18]-FDG Injection
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2016
Completion date
January 30, 2017
Enrollment
1,012 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

positron-emission tomography and cone-beam computed tomography